IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Arch Venture Management, LLC

Q3 2019 Holdings

Filed 2019-11-12 | 5 holdings | $91.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Syros Pharmaceuticals IncCOM87184Q107$40.0K3,855,05143.8%
Rubius Therapeutics IncCOM78116T103$20.6K2,618,35122.5%
Kura Oncology Inc(KURA)COM50127T109$13.7K906,30715.0%
Fate Therapeutics Inc(FATE)COM31189P102$11.1K716,39212.2%
Chiasma Inc(CHMA)COM16706W102$5.9K1,196,7766.5%